Omgeving

New York Core Neuroscience in New York

Logo van New York Core Neuroscience

Openingstijden

Maandag
08:00 - 17:00
Dinsdag
08:00 - 18:00
Woensdag
08:00 - 17:00
Donderdag
08:00 - 18:00

M 8am-5pm, Tu 8am-6pm, W 8am-5pm, Th 8am-6pm, F-Su Closed

Wijzig gegevens voor dit item

Opties voor het wijzigen van uw gegevens

Die Seite "New York Core Neuroscience" wordt beheerd door een agentschap.Neem contact op met uw agentschapspartner om de inhoud bij te werken.

Dit bericht wordt onderhouden door:

New York Core Neuroscience Artsen

35 35th St.
10016 New York

Beschrijving

Michael Hutchinson, MD, PhD

Dr. Hutchinson is a board-certified neurologist and senior faculty at the Icahn School of Medicine, Mount Sinai, Manhattan. His clinical interests include headaches, dementia, concussion, traumatic brain injury (TBI), Parkinson's Disease, multiple sclerosis, epilepsy, anxiety, and REM sleep disorders.  He has an extensive scientific background and brings a science-based approach to solving clinical problems.

During his residency at the University of Washington, Hutchinson used his knowledge of chaos theory to propose a new way of treating status epilepticus, the most lethal form of epilepsy. The treatment proved successful and is now standard-of-care in the US. Hutchinson later did a sabbatical at Queen Square, London, where Ian McDonald was pioneering the use of beta interferon as the first treatment for multiple sclerosis.

 

After residency training, Hutchinson underwent a neuroimaging fellowship in Los Angeles.

 

After arriving at NYU in 1994, Hutchinson pioneered the use of cholinesterase inhibitors as a treatment for the dementia of Parkinson's disease. At the time this was considered forbidden because it might make the patient physically worse, but Hutchinson argued that this premise was ill-conceived. Today, cholineserase inhibitors are standard-of-care in Parkinson's dementia. Hutchinson later developed a new way of treating acute relapses in multiple sclerosis, which puts the patient in charge, and has yielded impressive long-term results.

 

During his time at NYU, Hutchinson made early contributions to functional MRI, discovering that regional brain activations during cognitive tasks are accompanied by widespread deactivations.  In structural imaging, Hutchinson combined physics, neuropathology, and image processing to develop a robust MRI biomarker for Parkinson's disease.

 

In addition to certification in neurology, Hutchinson is certified in neuroimaging (MRI and CT of the brain and spine), which combines neuroana

0 Beoordelingen

Beoordeel direct als gast of Inloggen
Uw evaluatie:
Als je een commentaar schrijft als gast, ontvang je een e-mail waarin je het commentaar kunt activeren.
De opmerking is pas zichtbaar op onze site nadat deze is geactiveerd.
US

© 2024, Wogibtswas / Locabee. Alle merknamen en handelsmerken zijn eigendom van hun respectieve eigenaars. Alle informatie zonder garantie. Status 04.07.2024 23:10:49

UP

Kies je land en taal